Skip to main content

Table 6 Evolution of mean scores over time in quality of life and mood of patients with advanced cancer at baseline, 12, 18 and 24 weeks

From: Is early integration of palliative home care in oncology treatment feasible and acceptable for advanced cancer patients and their health care providers? A phase 2 mixed-methods study

Patients’ outcomes Range Assessment
Baseline (t0) 12 weeks (t1) 18 weeks (t2) 24 weeks (t3) P value
(N = 30) (N = 26) (N = 22) (N = 18)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
EORTC QLQ C-30
 Global QOL 0–100 60,5 ± 16 58 ± 17,7 61,9 ± 17,6 62,5 ± 17,2 0,81
 Physical functioning 0–100 60,9 ± 23,8 60,5 ± 23,2 60,9 ± 21,2 65,4 ± 23,1 0,90
 Role functioning 0–100 59,4 ± 31,5 51,3 ± 29,6 53 ± 28 55,6 ± 32,8 0,78
 Emotional functioning 0–100 69,6 ± 18,3 66 ± 24,6 67 ± 23,4 70,8 ± 24 0,88
 Cognitive functioning 0–100 75 ± 23,1 68 ± 25,4 75 ± 25,1 69,4 ± 29,8 0,67
 Social functioning 0–100 72,2 ± 23 73,1 ± 20,6 75,8 ± 19,1 69,4 ± 29,8 0,86
HADS
 HADS – anxiety 0–21 7,9 ± 4,1 7 ± 4 6,2 ± 4,3 7,5 ± 5,1 0,55
 HADS – depression 0–21 7,4 ± 3,6 7,3 ± 4,3 6,6 ± 3,7 7,1 ± 4,5 0,90
  1. EORTC QLQ C-30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (for all the EORTC QLQ C-30 scales the higher the score, the better quality of life); HADS Hospital Anxiety and Depression Scale (for both HADS subscales the higher the score, the higher the distress)
\